PNC Financial Services Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34K | Sell |
96
-766
| -89% | -$10.7K | ﹤0.01% | 4513 |
|
|
2025
Q1 | $11.6K | Buy |
862
+794
| +1,168% | +$10.7K | ﹤0.01% | 3771 |
|
|
2024
Q4 | $1.3K | Sell |
68
-7
| -9% | -$134 | ﹤0.01% | 4383 |
|
|
2024
Q3 | $1.71K | Buy |
75
+42
| +127% | +$955 | ﹤0.01% | 4322 |
|
|
2024
Q2 | $429 | Buy |
33
+13
| +65% | +$169 | ﹤0.01% | 4553 |
|
|
2024
Q1 | $350 | Sell |
20
-40
| -67% | -$700 | ﹤0.01% | 4535 |
|
|
2023
Q4 | $1.31K | Buy |
+60
| New | +$1.31K | ﹤0.01% | 4267 |
|